[email protected]
+1 941 755 6644



Welcome to the Archer Pharmaceuticals website! Use this panel to navigate all the pages of the site.

News & Press Room
For media inquiries, please contact us at 941 755 6644.


Archer Pharmaceuticals will present at the 2018 San Diego Health Impact Forum its most recent advances in the development of drugs for the treatment of Alzheimer’s disease.  Dr. Mike Mullan will be presenting in one of the “Groundbreaking Discoveries and Innovations” sessions and will be describing his current clinical development program that slows the advance of Alzheimer’s disease which has increasing worldwide incidence and prevalence.

For Immediate Release
Contact: Kristen Bridges (850) 222-2140
Tuesday, October 21, 2008

Sarasota, Fla. – A team of world-renowned scientists today announced the launch of Archer Pharmaceuticals, Inc., a new company that will use modern technologies for the identification of novel treatments for Alzheimer’s disease. Archer Pharmaceuticals, Inc., led by Chief Executive Officer Michael Mullan, M.B.B.S., Ph.D. and Chief Technical Officer Fiona Crawford, Ph.D., was created based on the groundbreaking research that their team has been conducting in Florida for the past five years.

Read More

Roskamp Institute scientists in Sarasota have a promising drug in trials in Europe. It switches the Alzheimer factory off.

The Sarasota Observer
By Heidi Kurpiela, Community Editor
Thursday, April 3, 2008

It starts as a protein, an organic compound of amino acids that is amorphous. Nebulous. Shaped like nothing, floating in the brain, passing through the blood barrier in small amounts. And like a pinch of vodka in soda water, they go unnoticed.

But over time and for whatever reason — scientists aren’t sure why —more and more of these proteins start accumulating in the brain, blanketing synapses in a sticky kind of plaque and like fine, fine hairs gathering in the bristles of a brush, the brain starts to clog with these things called beta-amyloids.

Under a microscope, the fibrous amyloids are no longer shapeless, nebulous things. They look like hairpins, twisty and stackable like Legos.

If this were a game of Tetris, you would work feverishly to clear the screen. This is an oversimplified metaphor for Alzheimer’s. But the description is not unlike what the scientists in white lab coats are doing on Whitfield Avenue in Sarasota.

Read More